Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Q1 2026 vs. Q4 2025
How the institutions holding Alterity Therapeutics Ltd changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 18 | 1 | 15 | −2 |
| Shares | 325.1K | 40 | 320.8K | −4.18K (−1.3%) |
| Value | $1.00M | $0 | $1.12M | +$117.5K (+11.7%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Alterity Therapeutics Ltd at the end of Q1 2026 but not at the end of Q4 2025.
None.
Sold out (2)
Institutions that held Alterity Therapeutics Ltd at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 10 | $31 |
| Citigroup Inc | 1 | $3 |
Not filed for Q1 2026 yet (1)
Institutions that held Alterity Therapeutics Ltd at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Motiv8 Investments LLC | 40 | $0 |